QL
COGT icon

Quarry LP’s Cogent Biosciences COGT Stock Holding History

Quarry LP’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271 Buy
+7
New +$245 ﹤0.01% 2255
2024
Q2 		– Sell
-1,500
Closed -$10.1K – 1838
2024
Q1 		$10.1K Buy
1,500
+317
+27% +$1.96K ﹤0.01% 1186
2023
Q4 		$6.96K Buy
+1,183
New +$9.06K ﹤0.01% 1183

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quarry LP's COGT Position: Q2 2026 in Review

Quarry LP opened a new position in Cogent Biosciences (COGT) in Q2 2026: 7 shares worth $271. The stake represents ﹤0.01% of the portfolio and ranks #2255 among its holdings. This is a return to the name: Quarry LP previously reported a position in COGT as recently as Q1 2024.

Quarry LP first reported a position in COGT in Q4 2023 and has held it in 3 quarters since. The position peaked at $10.1K in Q1 2024. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Quarry LP held 7 shares of Cogent Biosciences worth $271 as of Q2 2026.
  • Cogent Biosciences was a new Quarry LP position in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2255 holding.
  • Quarry LP first reported a position in Cogent Biosciences in Q4 2023 and has held it in 3 quarters since.
  • Quarry LP's Cogent Biosciences position peaked at $10.1K in Q1 2024.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.